Supplements
magnesium treats chronic constipation
In plain terms: Does magnesium relieve constipation?
Part of: 🧪 magnesium
Yes—magnesium oxide is a genuine osmotic laxative with solid trial support, one of magnesium's best-established uses.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Magnesium oxide is a genuine osmotic laxative and one of magnesium's best-supported uses: SR/MA and RCT evidence show it improves stool frequency/consistency in chronic idiopathic constipation, and it appears in dietary constipation guidance (albeit under-emphasized). This is a mechanism-backed, trial-supported effect — distinct from the softer supplement claims.
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Morishita et al. 2021 · Am J Gastroenterol | RCT | supports | moderate | Double-blind placebo-controlled RCT: magnesium oxide effective vs placebo for chronic idiopathic constipation (compared against senna). |
| Dimidi et al. 2025 · J Hum Nutr Diet | meta-analysis | supports | high | BDA evidence-based dietary guideline: magnesium oxide among supported strategies for chronic constipation. |
| van der Schoot et al. 2023 · Neurogastroenterol Motil | meta-analysis | supports | moderate | SR/MA of food/vitamin/mineral supplements for chronic constipation: magnesium oxide effective for stool output/symptoms. |
| Dimidi E et al 2025 · study_type: observational | meta-analysis | supports | high | BDA guideline: 4 systematic reviews/MAs, 75 RCTs total; 5 of 59 recommendation statements specifically address magnesium oxide as dietary supplement for CC |
| Hsiao PJ et al 2026 · study_type: observational | observational | tested-null | moderate | Taiwan cohort, non-dialysis CKD, MgO users vs non-users: matched aHR AKI 37.0, AKD 6.26, ESRD 3.13, arrhythmia 2.06, MI 1.86 (dose-response by CKD stage) |
| Dimidi 2025 · Proc Nutr Soc | observational | supports | low | Evidence review of dietary management of chronic constipation: MgO among strategies with supporting RCT/MA evidence, though under-recommended in guidelines. |
| Kessoku T et al 2025 · study_type: observational | observational | mixed | moderate | MgO(n=30) vs elobixibat(n=43) in CC: LODD improved 33% vs 65% (p<0.001); FDDV −0.1 vs 35mL; STC→NTC shift 37% vs 87% (p=0.003), EXB>MgO |
| Yoneda H et al 2026 · study_type: RCT | RCT | mixed | low | n=40 healthy, Mg-rich mineral water 1L/day 14d vs soft water: BSFS ↑ wk1&wk2 (p<0.05), ↑ SBM/CSBM freq, no safety concerns |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.